会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • T2k kinase assays
    • T2k激酶测定
    • US06365366B1
    • 2002-04-02
    • US09524435
    • 2000-03-13
    • Zhaodan Cao
    • Zhaodan Cao
    • C12Q142
    • C12Q1/485G01N33/573Y10S435/968
    • T2K kinase activity is detected by forming a mixture of a T2K kinase and a substrate; incubating the mixture under conditions whereby the kinase phosphorylates the substrate at a first rate; and detecting the first rate as an indication of the kinase activity. The substrate comprises SX1X2X3SX4 (SEQ ID NO:1) wherein X1 and X4 are aliphatic residues and both of the S residues are targets of the kinase, and especially, IKK&agr; or IKK&bgr;. In another embodiment, the mixture substrate comprises a particular IL-1 or TNF signaling cascade component. The mixture may be used to screen for agents which modulate the activity of the kinase, e.g. as an immuno-chemiluminescent assay.
    • 通过形成T2K激酶和底物的混合物来检测T2K激酶活性; 在使激酶以第一速率磷酸化底物的条件下孵育混合物; 并检测第一个速率作为激酶活性的指示。 底物包含SX1X2X3SX4(SEQ ID NO:1),其中X 1和X 4是脂族残基,并且S残基都是激酶的靶标,特别是IKKα或IKKβ。 在另一个实施方案中,混合物底物包含特定的IL-1或TNF信号传导级联组分。 该混合物可用于筛选调节激酶活性的试剂,例如, 作为免疫化学发光测定。
    • 13. 发明授权
    • Interleukin-1 receptor accessory proteins, nucleic acids and methods
    • 白细胞介素-1受体辅助蛋白,核酸和方法
    • US06280955B1
    • 2001-08-28
    • US08991944
    • 1997-12-16
    • Zhaodan Cao
    • Zhaodan Cao
    • C07K14705
    • C07K14/7155G01N2500/20
    • The invention provides methods and compositions relating to IL-1RAcP proteins that regulate cellular signal transduction and transcriptional activation, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed IL-1RAcP encoding nucleic acids purified from human cells. The invention provides isolated IL-1RAcP hybridization probes and primers capable of specifically hybridizing with the disclosed IL-1RAcP genes, IL-1RAcP-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
    • 本发明提供了与调节细胞信号转导和转录激活的IL-1RAcP蛋白相关的方法和组合物以及相关的核酸。 可以从编码从人细胞纯化的核酸的公开的IL-1RAcP转化的宿主细胞重组产生多肽。 本发明提供了能够与所公开的IL-1RAcP基因,IL-1RAcP特异性结合剂如特异性抗体特异性杂交的分离的IL-1RAcP杂交探针和引物,以及制备和使用受试者组合物在诊断,治疗和 生物制药行业。
    • 18. 发明授权
    • Human telomerase RNA interacting protein gene
    • 人端粒酶RNA相互作用蛋白基因
    • US5747317A
    • 1998-05-05
    • US676967
    • 1996-07-08
    • Zhaodan Cao
    • Zhaodan Cao
    • C12N9/12C07H21/04C12N1/20C12N15/00
    • C12N9/1241
    • The invention provides methods and compositions relating to a human telomerase and related nucleic acids, including four distinct human telomerase subunit proteins called p140, p105, p48 and p43 having human telomerae-specific activity. The proteins may be produced recombinantly from transformed host cells from the disclosed telomerase encoding nucleic acids or purified from human cells. Also included are human telomerase RNA components, as well as specific, functional derivative thereof. The invention provides isolated telomerase hybridization probes and primers capable of specifically hybridizing with the disclosed telomerase gene, telomerase-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
    • 本发明提供了与人类端粒酶和相关核酸相关的方法和组合物,包括具有人类端粒特异性活性的称为p140,p105,p48和p43的四种不同的人端粒酶亚基蛋白。 可以从所公开的编码端粒酶的核酸转化的宿主细胞重组产生蛋白质,或从人细胞纯化。 还包括人端粒酶RNA组分以及其具体的功能衍生物。 本发明提供了能够与所公开的端粒酶基因,端粒酶特异性结合剂如特异性抗体特异性杂交的分离的端粒酶杂交探针和引物,以及在诊断,治疗和生物制药工业中制备和使用该主题组合物的方法。